Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
10.20
-0.10 (-0.97%)
At close: Apr 28, 2026, 4:00 PM EDT
10.20
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Cross Country Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,054 | 1,344 | 2,020 | 2,803 | 1,677 | Upgrade
|
| Revenue Growth (YoY) | -21.56% | -33.46% | -27.95% | 67.20% | 100.46% | Upgrade
|
| Cost of Revenue | 840.72 | 1,070 | 1,569 | 2,179 | 1,302 | Upgrade
|
| Gross Profit | 213.57 | 274.25 | 450.41 | 624.46 | 375 | Upgrade
|
| Selling, General & Admin | 194.68 | 233.38 | 300.33 | 324.21 | 215.26 | Upgrade
|
| Other Operating Expenses | - | 1.97 | 1.13 | - | - | Upgrade
|
| Operating Expenses | 211.03 | 274.98 | 334.37 | 346.39 | 229.9 | Upgrade
|
| Operating Income | 2.54 | -0.73 | 116.04 | 278.06 | 145.1 | Upgrade
|
| Interest Expense | -2.22 | -2.19 | -8.09 | -14.39 | -6.87 | Upgrade
|
| Interest & Investment Income | 3.13 | 2.05 | 0.08 | 0.01 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.01 | 0.61 | -0.09 | 1.33 | 0.77 | Upgrade
|
| EBT Excluding Unusual Items | 3.44 | -0.26 | 107.95 | 265.01 | 139.01 | Upgrade
|
| Merger & Restructuring Charges | -0.35 | -11.44 | -2.61 | -2.59 | -3.73 | Upgrade
|
| Impairment of Goodwill | -71.26 | - | - | - | - | Upgrade
|
| Asset Writedown | -6.59 | - | -0.72 | -5.6 | -2.07 | Upgrade
|
| Legal Settlements | -2.75 | -4.7 | - | - | - | Upgrade
|
| Other Unusual Items | -6 | - | -1.72 | -3.73 | - | Upgrade
|
| Pretax Income | -83.51 | -16.4 | 102.89 | 253.1 | 133.21 | Upgrade
|
| Income Tax Expense | 11.34 | -1.84 | 30.26 | 67.12 | 1.21 | Upgrade
|
| Earnings From Continuing Operations | -94.85 | -14.56 | 72.63 | 185.98 | 132 | Upgrade
|
| Net Income | -94.85 | -14.56 | 72.63 | 185.98 | 132 | Upgrade
|
| Net Income to Common | -94.85 | -14.56 | 72.63 | 185.98 | 132 | Upgrade
|
| Net Income Growth | - | - | -60.95% | 40.89% | - | Upgrade
|
| Shares Outstanding (Basic) | 32 | 33 | 35 | 37 | 37 | Upgrade
|
| Shares Outstanding (Diluted) | 32 | 33 | 35 | 38 | 37 | Upgrade
|
| Shares Change (YoY) | -2.91% | -5.91% | -5.49% | 0.39% | 3.61% | Upgrade
|
| EPS (Basic) | -2.93 | -0.44 | 2.07 | 5.02 | 3.60 | Upgrade
|
| EPS (Diluted) | -2.93 | -0.44 | 2.05 | 4.95 | 3.53 | Upgrade
|
| EPS Growth | - | - | -58.59% | 40.23% | - | Upgrade
|
| Free Cash Flow | 40.09 | 111.4 | 234.52 | 125.26 | -92.79 | Upgrade
|
| Free Cash Flow Per Share | 1.24 | 3.34 | 6.61 | 3.34 | -2.48 | Upgrade
|
| Gross Margin | 20.26% | 20.41% | 22.30% | 22.27% | 22.37% | Upgrade
|
| Operating Margin | 0.24% | -0.05% | 5.75% | 9.92% | 8.65% | Upgrade
|
| Profit Margin | -9.00% | -1.08% | 3.60% | 6.63% | 7.87% | Upgrade
|
| Free Cash Flow Margin | 3.80% | 8.29% | 11.61% | 4.47% | -5.53% | Upgrade
|
| EBITDA | 18.53 | 16.78 | 133.89 | 290.04 | 154.56 | Upgrade
|
| EBITDA Margin | 1.76% | 1.25% | 6.63% | 10.35% | 9.22% | Upgrade
|
| D&A For EBITDA | 15.99 | 17.5 | 17.85 | 11.98 | 9.45 | Upgrade
|
| EBIT | 2.54 | -0.73 | 116.04 | 278.06 | 145.1 | Upgrade
|
| EBIT Margin | 0.24% | -0.05% | 5.75% | 9.92% | 8.65% | Upgrade
|
| Effective Tax Rate | - | - | 29.41% | 26.52% | 0.91% | Upgrade
|
| Advertising Expenses | 7.5 | 8.5 | 11.5 | 16.1 | 9.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.